[EATG Global HIV News daily digest] Digest #210-2009

[EATG Global HIV News daily digest]

Global HIV News Daily Digest

Copied as fair use  -  Ana  -




Latest Headlines




  Tibotec Therapeutics launches GRACE campaign for women and people of color living with HIV/AIDS 
  Pharma Industry Thursday 03 December 2009
					
  
Through a comprehensive campaign including local educational events,
media outreach and a new Web site, the company is sharing learnings
from the GRACE study, the largest clinical trial in North America among
women with HIV who had previously taken HIV medications.
  SOURCE:
Tibotec Therapeutics




  The first international treaty banning sexual orientation discrimination comes into force today – the Treaty of Lisbon
  EU Policy Thursday 03 December 2009
					
  
Any discrimination based on any ground such as sex, race, colour,
ethnic or social origin, genetic features, language, religion or
belief, political or any other opinion, membership of a national
minority, property, birth, disability, age or sexual orientation shall
be prohibited.
  SOURCE:
ILGA-Europe




  U.S. unveils 5-year PEPFAR strategy
  World Policy Thursday 03 December 2009
					
  
The PEPFAR plan aims to "provide 4 million people with treatment by
financial year 2014, an increase from the current treatment levels of
about 2.4 million."
  SOURCE:
Kaiser Daily Global Health Policy Report




  Annual
rate of newly diagnosed HIV infections in Europe more than doubled
between 2000 and 2008, according to a report released for World AIDS Day
  Epidemiology Thursday 03 December 2009
					
  
Nearly 51 600 people in the WHO European Region were newly diagnosed as
infected with HIV in 2008, more than double the annual rate in 2000.
  SOURCE:
EurActiv.com




  Pharma industry prepares for end of 'blockbuster medicines'  
  EU Policy Thursday 03 December 2009
					
  
The days of the $1 billion blockbuster drug are over, according to a
senior industry researcher. Big pharma is now investing in finding
multiple uses for medicines developed to treat rare diseases, but is
pushing the EU for patent extensions to make research worthwhile.
  SOURCE:
EurActiv.com




  Venture capital drought hurting biopharma SMEs  
  EU Policy Thursday 03 December 2009
					
  
Europe's biopharmaceutical sector is under severe pressure due to the
reluctance of investors to gamble on high-risk drug development
projects, according to a new report sponsored by the EU.
  SOURCE:
EurActiv.com




  EU balancing competition with innovation in pharma sector  
  EU Policy Thursday 03 December 2009
					
  
The top official at the EU's competition office has told the European
Parliament that some medicine makers effectively represent an obstacle
to making savings in the health sector. However, he acknowledged that
research-based pharma companies must be incentivised to produce new
medicines.
  SOURCE:
EurActiv.com




  EU health policy clout 'strengthened' with new treaty  
  EU Policy Thursday 03 December 2009
					
  
Even if it re-asserts the powers of EU member states on public health
policies, the Lisbon Treaty also further develops the scope for
European action in this area, says the World Health Organisation (WHO).
  SOURCE:
EurActiv.com




  Researchers have identified the first genetic resistance factor against tuberculosis infection
  Tuberculosis & Malaria Thursday 03 December 2009
					
  
"If we can make everyone resistant to tuberculosis infection, this major public health problem could be wiped off the map."
  SOURCE:
MUHC




  Breakthrough tuberculosis diagnostic application based on digital imagery analysis excels in South African clinical trial
  Tuberculosis & Malaria Thursday 03 December 2009
					
  
Signature Mapping TBDx(™) (SM TBDx) is an automated diagnostic solution
using sophisticated detection algorithms to identify TB under
microscopy in sputum samples, at the laboratory level.
  SOURCE:
Guardian Technologies International, Inc.




  IAVI 2009 World AIDS Day statement 
  Prevention Thursday 03 December 2009
					
  
Achieving universal access: the way forward

IAVI calls for strong and sustained global investment in new HIV prevention tools.


  SOURCE:
IAVI




  Young HIV-positive women face higher heart disease risks
  Treatment Thursday 03 December 2009
					
  
Tests conducted by Mulligan’s team included cholesterol and
triglyceride levels, blood sugar insulin levels, fat distribution
assessed by dual energy X-ray absorptiometry (DEXA) scans, and high
sensitivity C-reactive protein (hs-CRP).
  SOURCE:
AIDSmeds.com


----------------------------------------------------
DISCLAIMER
The articles in this digest represent a diversity of opinions on topics
of interest to the HIV treatment activist community. The EATG is not
responsible for their content. The articles posted in this digest do
not necessarily reflect EATG views or opinions.
FAIR USE NOTICE
The digest may contain copyrighted material which has not always been
specifically authorised by the copyright owner. Such material is made
available for educational purposes to advance the understanding of
scientific, ethical, legal and social issues. It is believed that this
constitutes a 'fair use' of any such copyrighted material. This
material is distributed without profit.


 

Information in this digest was accurately quoted during its compilation.




      
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.eatg.org/pipermail/eatg-forum_eatg.org/attachments/20091203/e3156090/attachment-0001.html>